Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03016312 |
|---|---|
| Brief Title: | A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen (IMbassador250) |
| First Submitted : | January 9, 2017 |
| First Submitted that Met QC Criteria : | January 9, 2017 |
| First Posted : | January 10, 2017 (Estimate) |
| Results First Submitted : | April 5, 2021 |
| Results First Submitted that Met QC Criteria : | April 5, 2021 |
| Results First Posted : | April 30, 2021 |
| Last Update Submitted that Met QC Criteria : | January 23, 2023 |
| Last Update Posted : | February 17, 2023 |